These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 18280369)

  • 1. Early signs of liver failure after low-dose interferon alfa-2b for cutaneous melanoma.
    Ammoury A; El Sayed F; Farah C; Bazex J
    J Am Acad Dermatol; 2008 Mar; 58(3):532-3. PubMed ID: 18280369
    [No Abstract]   [Full Text] [Related]  

  • 2. Delayed wound healing following treatment with low-dose interferon alfa-2b for cutaneous melanoma.
    Ammoury AF; El Sayed F; Bazex J
    Arch Dermatol; 2007 Oct; 143(10):1339-40. PubMed ID: 17938359
    [No Abstract]   [Full Text] [Related]  

  • 3. Present status and future prospects for adjuvant therapy of melanoma: time to build upon the foundation of high-dose interferon alfa-2b.
    Moschos SJ; Kirkwood JM; Konstantinopoulos PA
    J Clin Oncol; 2004 Jan; 22(1):11-4. PubMed ID: 14665613
    [No Abstract]   [Full Text] [Related]  

  • 4. Lipoatrophy associated with interferon alfa adjuvant therapy for melanoma.
    Vallés L; González M; Polo I; Enguita AB; Vanaclocha F; Ortiz-Romero PL
    Arch Dermatol; 2009 Jan; 145(1):98-9. PubMed ID: 19153363
    [No Abstract]   [Full Text] [Related]  

  • 5. Adjuvant interferon in high-risk melanoma: the AIM HIGH Study--United Kingdom Coordinating Committee on Cancer Research randomized study of adjuvant low-dose extended-duration interferon Alfa-2a in high-risk resected malignant melanoma.
    Hancock BW; Wheatley K; Harris S; Ives N; Harrison G; Horsman JM; Middleton MR; Thatcher N; Lorigan PC; Marsden JR; Burrows L; Gore M
    J Clin Oncol; 2004 Jan; 22(1):53-61. PubMed ID: 14665609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Grand mal seizure induced by interferon-alpha-2b.
    Kors C; Milling A; Hofmann M; Sterry W; Trefzer U
    J Eur Acad Dermatol Venereol; 2006 Apr; 20(4):473-4. PubMed ID: 16643159
    [No Abstract]   [Full Text] [Related]  

  • 7. Tolerability of intensified intravenous interferon alfa-2b versus the ECOG 1684 schedule as adjuvant therapy for stage III melanoma: a randomized phase III Italian Melanoma Inter-group trial (IMI - Mel.A.) [ISRCTN75125874].
    Chiarion-Sileni V; Del Bianco P; Romanini A; Guida M; Paccagnella A; Dalla Palma M; Naglieri E; Ridolfi R; Silvestri B; Michiara M; De Salvo GL
    BMC Cancer; 2006 Feb; 6():44. PubMed ID: 16504154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant interferon therapy for melanoma: high-dose, low-dose, no dose, which dose?
    Schuchter LM
    J Clin Oncol; 2004 Jan; 22(1):7-10. PubMed ID: 14665612
    [No Abstract]   [Full Text] [Related]  

  • 9. Quality of life in patients receiving high-dose interferon alfa-2b after resected high-risk melanoma.
    Mohr P; Hauschild A; Trefzer U; Weichenthal M
    J Clin Oncol; 2009 Aug; 27(24):e70; author reply e71. PubMed ID: 19620476
    [No Abstract]   [Full Text] [Related]  

  • 10. Post-surgery adjuvant therapy with intermediate doses of interferon alfa 2b versus observation in patients with stage IIb/III melanoma (EORTC 18952): randomised controlled trial.
    Eggermont AM; Suciu S; MacKie R; Ruka W; Testori A; Kruit W; Punt CJ; Delauney M; Sales F; Groenewegen G; Ruiter DJ; Jagiello I; Stoitchkov K; Keilholz U; Lienard D;
    Lancet; 2005 Oct; 366(9492):1189-96. PubMed ID: 16198768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nursing management of patients with malignant melanoma receiving adjuvant alpha interferon-2b.
    Kiley KE; Gale DM
    Clin J Oncol Nurs; 1998 Jan; 2(1):11-6. PubMed ID: 9481251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Livedo reticularis associated with interferon alpha therapy in two melanoma patients.
    Ruiz-Genao DP; García-F-Villalta MJ; Hernández-Núñez A; Ríos-Buceta L; Fernández-Herrera J; García-Díez A
    J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):252-4. PubMed ID: 15752306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerability of adjuvant high-dose interferon alfa-2b: 1 month versus 1 year--a Hellenic Cooperative Oncology Group study.
    Gogas H; Bafaloukos D; Ioannovich J; Skarlos D; Polyzos A; Fountzilas G; Kalofonos HP; Aravantinos G; Tsoutsos D; Panagiotou P; Frangia K; Petrakopoulou T; Pectasides D;
    Anticancer Res; 2004; 24(3b):1947-52. PubMed ID: 15274382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meyerson's phenomenon in a patient affected by high-risk melanoma under treatment with interferon-α.
    Zonta E; Chiarion V; Zarian H; Peserico A; Alaibac M
    Melanoma Res; 2012 Jun; 22(3):284-5. PubMed ID: 22543678
    [No Abstract]   [Full Text] [Related]  

  • 15. Livedo reticularis: a side effect of interferon therapy in a pediatric patient with melanoma.
    Fox M; Tahan S; Kim CC
    Pediatr Dermatol; 2012; 29(3):333-5. PubMed ID: 21575046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mediastinal sarcoidosis induced by high-dose alpha-2-interferon therapy in a patient with malignant melanoma.
    Massaguer S; Sánchez M; Castel T
    Eur Radiol; 2004 Sep; 14(9):1716-7. PubMed ID: 14740162
    [No Abstract]   [Full Text] [Related]  

  • 17. Three consecutive phase II studies of recombinant interferon alfa-2a in advanced malignant melanoma. Updated analyses.
    Creagan ET; Ahmann DL; Frytak S; Long HJ; Chang MN; Itri LM
    Cancer; 1987 Feb; 59(3 Suppl):638-46. PubMed ID: 10822463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous sarcoidosis by interferon therapy in a patient with melanoma.
    Alonso-Pérez A; Ballestero-Díez M; Fraga J; García-Díez A; Fernández-Herrera J
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1328-9. PubMed ID: 17062055
    [No Abstract]   [Full Text] [Related]  

  • 19. [Recombinant interferon alfa-2b in the treatment of patients with skin melanoma].
    Korovin SI
    Lik Sprava; 1998; (2):139-41. PubMed ID: 9670687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential drug-drug interaction between interferon alfa-2b and gemfibrozil in a patient with malignant melanoma.
    Wong SF; Jakowatz JG; Taheri R
    Clin Ther; 2005 Dec; 27(12):1942-8. PubMed ID: 16507380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.